Showing results (3121-3130 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 18, 2021
Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology CenterAnuj K Patel, Ritika Abhyankar, Lauren K Brais, et al.
The Oncologist|August 23, 2021
Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical TrialMiao Xiang, Xiyue Yang, Surong Ren, et al.
The Oncologist|April 24, 2020
Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene AmplificationDirk Hempel, Thomas Wieland, Beate Solfrank, et al.
The Oncologist|May 14, 2020
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar CarcinomaImane El Dika, Robert J Mayer, Alan P Venook, et al.
The Oncologist|May 14, 2020
Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?Mitchell S von Itzstein, Shaheen Khan, Vinita Popat, et al.
The Oncologist|May 12, 2020
Prolonged Opioid Use After Surgery for Early-Stage Breast CancerChan Shen, J Douglas Thornton, Dian Gu, et al.
The Oncologist|April 28, 2020
Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of LiteratureAdam Amlani, Claire Barber, Aurore Fifi-Mah, et al.
The Oncologist|April 8, 2020
Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical RecordsShouhua Yang, Yuan Zhang, Jing Cai, et al.
The Oncologist|June 20, 2020
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World ExperienceLaura Bonanno, Alberto Pavan, Alessandra Ferro, et al.
The Oncologist|May 4, 2021
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaHani Babiker, Irene Brana, Daruka Mahadevan, et al.
Pageof 571